Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mostert

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
ACS Chemical Biology|September 28, 2021
The Coenzyme A Level Modulator Hopantenate (HoPan) Inhibits Phosphopantotenoylcysteine Synthetase ActivityKonrad J Mostert, Nandini Sharma, Marianne van der Zwaag, et al.
Cell and Tissue Research|June 1, 1989
Effect of phlebotomy on the ferritin iron content in the rat liver as determined morphometrically with the use of electron energy loss spectroscopyM I Cleton, L J Mostert, L W Sorber, et al.
Equine Veterinary Journal|August 15, 1998
Water and electrolyte intake and output in conditioned Thoroughbred horses transported by roadJ S van den Berg, A J Guthrie, R A Meintjes, et al.
Medchemcomm|March 25, 2020
Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801Riyad Domingo, Renier van der Westhuyzen, Anton R Hamann, et al.
Multiple Sclerosis and Related Disorders|April 17, 2023
Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosisE M E Coerver, A Bourass, M H J Wessels, et al.
Advances in Enzyme Regulation|July 19, 2002
In situ detection of phospholipid and phosphoinositide metabolismGlenn D Prestwich, Riyan Chen, Li Feng, et al.
Multiple Sclerosis and Related Disorders|October 6, 2024
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosisE Coerver, L Schoof, L Hogenboom, et al.
ACS Infectious Diseases|June 3, 2025
Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC's PPCS Activity in <i>Mycobacterium tuberculosis</i> and <i>Staphylococcus aureus</i>Timothy J Kotzé, Konrad J Mostert, Riyad Domingo, et al.
Life Science Alliance|November 21, 2018
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activityCaroline Giessner, Virginie Millet, Konrad J Mostert, et al.
Journal of Neurology|July 23, 2025
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)W H Fung, M H J Wessels, E M E Coerver, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
ACS Chemical Biology|September 28, 2021
The Coenzyme A Level Modulator Hopantenate (HoPan) Inhibits Phosphopantotenoylcysteine Synthetase ActivityKonrad J Mostert, Nandini Sharma, Marianne van der Zwaag, et al.
Cell and Tissue Research|June 1, 1989
Effect of phlebotomy on the ferritin iron content in the rat liver as determined morphometrically with the use of electron energy loss spectroscopyM I Cleton, L J Mostert, L W Sorber, et al.
Equine Veterinary Journal|August 15, 1998
Water and electrolyte intake and output in conditioned Thoroughbred horses transported by roadJ S van den Berg, A J Guthrie, R A Meintjes, et al.
Medchemcomm|March 25, 2020
Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801Riyad Domingo, Renier van der Westhuyzen, Anton R Hamann, et al.
Multiple Sclerosis and Related Disorders|April 17, 2023
Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosisE M E Coerver, A Bourass, M H J Wessels, et al.
Advances in Enzyme Regulation|July 19, 2002
In situ detection of phospholipid and phosphoinositide metabolismGlenn D Prestwich, Riyan Chen, Li Feng, et al.
Multiple Sclerosis and Related Disorders|October 6, 2024
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosisE Coerver, L Schoof, L Hogenboom, et al.
ACS Infectious Diseases|June 3, 2025
Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC's PPCS Activity in <i>Mycobacterium tuberculosis</i> and <i>Staphylococcus aureus</i>Timothy J Kotzé, Konrad J Mostert, Riyad Domingo, et al.
Life Science Alliance|November 21, 2018
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activityCaroline Giessner, Virginie Millet, Konrad J Mostert, et al.
Journal of Neurology|July 23, 2025
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)W H Fung, M H J Wessels, E M E Coerver, et al.
Pageof 3